Etiology and Management of Chronic Valve Disease in Antiphospholipid Antibody Syndrome and Systemic Lupus Erythematosus
- 16 June 2010
- journal article
- case report
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 10 (2) , 133-139
- https://doi.org/10.1111/j.1540-8191.1995.tb01231.x
Abstract
Unlike the Libman-Sacks vegetations of acute systemic lupus erythematosus (SLE), which are usually asymptomatic, valve involvement in chronic SLE and primary antiphospholipid antibody syndrome (APLAS) is similar to that of chronic rheumatic disease. Typical findings include valve thickening and nodularity, poor coaptation, and regurgitation. Elevated levels of antiphospholipid antibodies have been associated with the development of these valvular abnormalities in some but not all reported cases, and there are undoubtedly other etiologic cofactors. When cardiac valvular replacement is required, special attention must be given to preoperative reduction of elevated antibody levels, prevention of intraoperative thromboembolism, and prompt and aggressive postoperative anticoagulation.Keywords
This publication has 26 references indexed in Scilit:
- A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosusAmerican Heart Journal, 1993
- Prevalence of anticardiolipin antibody in isolated mitral or aortic regurgitation, or both, and possible relation to cerebral ischemic eventsThe American Journal of Cardiology, 1992
- Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosusThe Lancet, 1990
- Cardiac involvement in systemic lupus erythematosus detected by echocardiographyThe American Journal of Cardiology, 1990
- The “Primary” Antiphospholipid SyndromeMedicine, 1989
- Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions, and transient ischaemic attacks.Annals of the Rheumatic Diseases, 1988
- Prevalence, Morphologic Types, and Evolution of Cardiac Valvular Disease in Systemic Lupus ErythematosusNew England Journal of Medicine, 1988
- Fatal cardiac failure due to myocardial microthrombi in systemic lupus erythematosusBMJ, 1988
- Mitral valve replacement for mitral stenosis caused by Libman-Sacks endocarditis.Heart, 1979
- Systemic lupus erythematosus as a cause of severe mitral regurgitation: New problem in an old diseaseThe American Journal of Cardiology, 1975